These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin). Bauernfeind A, Schweighart S, Eberlein E, Jungwirth R. Infection; 1991 Sep; 19 Suppl 5():S264-75. PubMed ID: 1664418 [Abstract] [Full Text] [Related]
23. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides. Fu KP, Neu HC. J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097 [Abstract] [Full Text] [Related]
24. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime]. Le Noc P, Bryskier A, Le Noc D. Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744 [Abstract] [Full Text] [Related]
39. Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa. Neu HC, Labthavikul P. Antimicrob Agents Chemother; 1982 Jan; 21(1):11-8. PubMed ID: 6805421 [Abstract] [Full Text] [Related]